Silvia Taylor | SVP, IR and Corporate Affairs |
Stan Erck | President and CEO |
Gregory Glenn | President, R&D |
John Trizzino | Chief Commercial Officer and Chief Business Officer |
Gregory Covino | CFO |
Filip Dubovsky | CMO |
Kelechi Chikere | Jefferies |
Eric Joseph | JPMorgan |
Charles Duncan | Cantor Fitzgerald |
Mayank Mamtani | B. Riley Securities |
Vernon Bernardino | H. C. Wainwright |
Ladies and gentlemen, thank you for standing by, and welcome to the Novavax' Fourth Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Silvia Taylor, you may begin.